Search Results
Sep 25, 2025, 07:00 ET Conquer Every Corner in the 2026 Toyota GR Corolla
suite includes: Pre-Collision System with Pedestrian Detection: Pre-Collision System with Pedestrian Detection (PCS w/PD) is designed to help detect a vehicle, pedestrian, bicyclist or motorcyclist and provide an audio/visual forward collision warning under certain circumstances.
More news about: Toyota Motor North America
Sep 25, 2025, 06:45 ET Canada Nickel Reports Additional Positive Exploration Drilling Results at Midlothian Nickel Sulphide Property
Co % Pd g/t Pt g/t
More news about: Canada Nickel Company Inc.
Sep 25, 2025, 06:30 ET Trimble Machine Control Now Integrates with Vermeer Remote Control Pile Drivers to Deliver Greater Automation on Solar Farm Jobsites
Trimble® today announced the addition of the Trimble Groundworks machine control system to the Vermeer PD10R and PD25R remote control pile drivers. This system represents a significant step forward in machine automation, improving productivity in the construction
More news about: Trimble
Sep 25, 2025, 06:30 ET AL-S Pharma Appoints Internationally Recognized Neurologist and Clinical Trial Expert Prof. Dr. Angela Genge as Chief Medical Officer
orphan drug designations from FDA, EMA and Swissmedic. The Phase 2 study completed by AL-S Pharma evaluated the safety, tolerability, pharmacodynamic (PD) markers, and pharmacokinetics (PK) of AP-101 in patients with sporadic ALS and patients with mutations in the SOD1 gene. About AL-S Pharma
More news about: AL-S Pharma AG
Sep 24, 2025, 09:00 ET Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials
lymphocytes and classifies immune phenotypes from H&E whole slide images. The Lunit SCOPE suite includes AI-powered tools such as SCOPE IO, SCOPE PD-L1, and SCOPE uIHC. Several of the world's largest pharmaceutical companies have already published their use of these solutions in research settings to
More news about: Lunit
Sep 24, 2025, 07:00 ET Pathios Therapeutics Appoints Jon Wigginton, M.D., as Non-Executive Director
company's immuno-oncology portfolio, including checkpoint inhibitors such as anti-PD-1 (Opdivo®) and anti-PD-L1 (BMS-936559), checkpoint inhibitor-based combinations including anti-CTLA-4 (Yervoy®)/anti-PD-1 (Opdivo®) among others, and a spectrum of other I-O agents. He also
More news about: Pathios Therapeutics
Sep 24, 2025, 07:00 ET Marengo to Present a Late-breaking Clinical Oral Abstract at ESMO 2025 on Initial Phase 2 Clinical Data of Invikafusp Monotherapy Activity in Patients with Antigen-Rich Solid Tumors Resistant to Immune Checkpoint Blockade
tolerability, and preliminary efficacy of invikafusp alfa as a monotherapy in biomarker-selected patients with advanced antigen-rich solid tumors, including PD-1 refractory and rare tumor types. The trial consists of two parts: Phase 1 dose escalation and Phase 2 dose expansion. For more information, visit
More news about: Marengo Therapeutics
Sep 24, 2025, 07:00 ET SystImmune, Inc. to Present New Clinical Data on Izalontamab Brengitecan and BL-M07D1 Highlighting Strength of Differentiated Antibody Drug Conjugate (ADC) Platform
of ovarian cancer in ChinaSafety and efficacy results of iza-bren in combination with serplulimab, an anti-PD-1 monoclonal antibody, in patients with extensive-stage small cell lung cancer in ChinaDemonstrating
More news about: SystImmune, Inc.
Sep 23, 2025, 09:00 ET Parkinson's Foundation Announces the "Paul Oreffice Innovations in Care Awards"
health and quality of life for people with Parkinson's disease (PD). Now open to clinicians of all stages, the two-year awards provide pilot funding for clinically-oriented research of new care delivery models for people living with PD.
More news about: Parkinson's Foundation
Sep 23, 2025, 09:00 ET LISEN Launches New Retractable Cable Car Charger Series, Fully Compatible with iPhone 17
USB-A and Type-C ports, meeting the charging needs of tablets, various smartphones, earbuds, and more, with very strong compatibility. It supports PD3.0, QC, and other fast charging protocols, with a maximum output of 69W fast charging power. In actual use, the retractable design of the USB-C
More news about: LisenTech
Sep 23, 2025, 04:57 ET Kelun-Biotech to Present Results from Multiple Clinical Studies at the 2025 ESMO Congress
Title: Sacituzumab tirumotecan (sac-TMT) + pembrolizumab[1] (pembro) for treatment-naïve advanced PD-L1 positive NSCLC: results from the Phase 2 MK-2870-003/SKB264-II-04 studyPresentation Type: PosterPresentation #: 1949PDate
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sep 23, 2025, 01:29 ET Schweden, das erste Land auf Rezept
Gesundheit zugutekommen können, und ich bin offen dafür, Schweden auf Rezept zu verschreiben, wenn meine Patientinnen und Patienten dies wünschen." sagt PD Dr. Michael Jeitler, MD, Charité Berlin and University of Tübingen. Zudem unterstreicht
More news about: Visit Sweden AB
Sep 22, 2025, 22:56 ET Ivonescimab HARMONi-6 Results Selected for ESMO 2025 LBA; Final Phase III Results of Cadonilimab as First-Line Therapy for Advanced Gastric Cancer to Be Published as an Oral Presentation
ivonescimab has outperformed a PD-1 inhibitor-based regimen, reinforcing its breakthrough clinical value. The promising results thus far affirm that ivonescimab provides significant advancements in clinical treatment for NSCLC, whether compared to PD-1 monotherapy, PD-1 plus chemotherapy, or VEGF-targeted
More news about: Akeso, Inc.
Sep 22, 2025, 11:13 ET Parkinson's Disease Therapeutics Market Size to Hit US$ 12.83 Billion by 2033, Report by DataM Intelligence
and only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of motor fluctuations in adults with advanced Parkinson's disease (PD).Related Reports:
More news about: DataM Intelligence 4 Market Research LLP
Sep 22, 2025, 09:29 ET Power Metallic Reports High Grade Assays and Provides Summer Update
Cu Pd Pt
More news about: Power Metallic Mines Inc.
Sep 22, 2025, 09:00 ET Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets
total to eight: PD-L1, HER2, EGFR(S468R mutant), ACVR2A/B, FZD7, ALK7, CD98hc, and IL-11. Notably, IL-11 represents a target without any known antibody complex structure, highlighting the platform's capacity to tackle previously unexplored targets. For a designed antibody against PD-L1, Galux experimentally
More news about: Galux
Sep 22, 2025, 09:00 ET ASUS Announces ExpertBook P3 designed for the Small and Medium Sized Business
I/O ports 2 x USB 3.2 Gen 2 Type-C (DP and PD 3.0 support) 2 x USB 3.2 Gen 1 Type-A 1
More news about: ASUS Computer International
Sep 22, 2025, 02:51 ET Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer
therapies such as ivonescimab and cadonilimab (PD-1/CTLA-4 bispecific antibody), as well as potentially first -in-class candidates such as AK130 and AK146D1 (Trop2/Nectin4 bispecific ADC). Preclinical studies indicate that dual blockade of the PD-1/VEGF and TIGIT/TGF-β pathways has synergistic
More news about: Akeso, Inc.
Sep 19, 2025, 10:01 ET Liver Cancer Therapeutics Market Size Surpasses USD 13.16 Billion by 2032, Increasing at a CAGR of 16.5% from 2025 to 2033
in June 2025, Ono Pharmaceutical Co., Ltd. and Bristol-Myers Squibb K.K. received supplemental approval for their anti-PD-1 antibody, Opdivo, and BMSKK's anti-CTLA-4 antibody, Yervoy, in combination therapy in Japan to expand their use for
More news about: DataM Intelligence 4 Market Research LLP
Sep 19, 2025, 08:00 ET Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025
preclinical to commercial stages and includes several in-house discovered programs, including ATG-022 (CLDN18.2 ADC), ATG-037 (oral CD73 inhibitor), ATG-101 (PD-L1 × 4-1BB bispecific antibody), ATG-031 (CD24-targeting macrophage activator), and ATG-042 (oral PRMT5-MTA inhibitor). Antengene has also developed
More news about: Antengene Corporation Limited
Sep 18, 2025, 17:31 ET NF-κB Inhibitors Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight
BioVie announced that patient enrollment is now open for the Phase II SUNRISE-PD clinical trial evaluating the safety and efficacy of bezisterim on motor and non-motor symptoms in patients with Parkinson's disease (PD) who haven't been treated with carbidopa/levodopa. The first patient in the trial
More news about: DelveInsight Business Research, LLP
Sep 18, 2025, 08:45 ET Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
global randomized Phase 2 trial (NCT06449209) evaluating pumitamig (also known as BNT327 or BMS986545), an investigational bispecific antibody targeting PD-L1 x VEGF-A, plus chemotherapy in patients with extensive-stage small cell lung cancer ("ES-SCLC"). The data, which are consistent with data presented
More news about: MarketNewsUpdates
Sep 18, 2025, 07:00 ET Marengo Therapeutics Advances STARt-002 Clinical Trial into Phase 2 Cohort Expansion Evaluating Invikafusp Alfa with TROP2-directed ADC TRODELVY® in Metastatic Breast Cancer
"As highlighted at recent oral presentations at major scientific conferences, invikafusp has already demonstrated promising single-agent activity in PD-1 resistant tumors including breast cancer," said Kevin Chin, M.D., Chief Medical Officer of Marengo Therapeutics. "Advancing
More news about: Marengo Therapeutics
Sep 17, 2025, 13:22 ET Kolmar Korea promove "beleza limpa" com inovações que vão desde embalagens ecológicas até P&D
multimedia:https://www.prnewswire.com/br/comunicados-para-a-imprensa/kolmar-korea-promove-beleza-limpa-com-inovacoes-que-vao-desde-embalagens-ecologicas-ate-pd-302559511.html
More news about: Kolmar Korea
Sep 17, 2025, 12:00 ET LattePanda IOTA Debuts: Palm-sized x86 Single-Board Computer with Intel N150 Delivers Significant Performance Leap
1080@60HzUSB Ports: 3 x USB 3.2 Gen 2 Type A (10Gbps)1 x USB 2.0 Pin Header1x USB Type-C PD 15V (Power Input Only)Network: 1GbE RJ45 Port (Support WOL)Operating System: Windows 10 & 11, ubuntu 22.04 &
More news about: LattePanda